Korean J Gastroenterol.  2020 Oct;76(4):185-190. 10.4166/kjg.2020.76.4.185.

Association between Inflammatory Bowel Disease and Lactose Intolerance: Fact or Fiction

• Asfari MM
• Sarmini MT
• Kendrick K
• Hudgi A
• Uy P
• Sridhar S
• Sifuentes H

• KMID: 2507765
• DOI: http://doi.org/10.4166/kjg.2020.76.4.185

Abstract

Background/Aims
Inflammatory bowel disease (IBD) is a complex condition precipitated by genetic susceptibility and possibly a disturbed microbiome. The role of dairy foods in IBD is controversial. This study examined the association between lactose intolerance (LI) and IBD.
Methods
Data on hospital admissions of all IBD adult patients were extracted from the National Inpatient Sample database between 2004 and 2014. The comorbidities and outcomes of interest were defined by querying all the diagnostic and procedural fields for the corresponding International Classification of Diseases 9th version (ICD-9) codes. Patients with IBD were defined as the “study group,” and the patients who did not have IBD were defined as the “control group”. LI was identified in both groups using the ICD-9 codes. Multivariate logistic regression was performed to examine the association between IBD and LI.
Results
The total population was 71,342,237 patients, of which 598,129 (0.83%) had IBD. The IBD patients were younger (52 years vs. 57 years) and with fewer females (57.5% vs. 60.1%) (p<0.001 for all). After adjusting for the potential confounding factors, the IBD group had a significantly higher rate of LI (OR 2.71, 95% CI 2.55-2.88, p<0.001) compared to the non-IBD group. The findings were similar on the further stratification of IBD into Crohn’s disease compared to the control group (OR 2.70, 95% CI 2.50-2.92, p<0.001) and ulcerative colitis compared to the control group (OR 2.71, 95% CI 2.46-2.98, p<0.001).
Conclusions
IBD patients have a 2.7 times higher risk of LI. Screening for LI in this population is warranted to avoid confusing or overlapping symptomatology.

Keyword

Lactose intolerance; Inflammatory bowel diseases; Colitis, ulcerative; Crohn disease; NIS

Figure

• 

  Fig. 1 Association of IBD with LI. IBD, inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis; LI, lactose intolerance; CI, confidence interval.

Reference

1. Kappelman MD, Moore KR, Allen JK, Cook SF. 2013; Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured us population. Dig Dis Sci. 58:519–525. DOI: 10.1007/s10620-012-2371-5. PMID: 22926499. PMCID: PMC3576554.

2. M'Koma AE. 2013; Inflammatory bowel disease : an expanding global health problem. Clin Med Insights Gastroenterol. 6:33–47. DOI: 10.4137/CGast.S12731. PMID: 24833941. PMCID: PMC4020403.

3. Sairenji T, Collins KL, Evans DV. 2017; An update on inflammatory bowel disease. Prim Care. 44:673–692. DOI: 10.1016/j.pop.2017.07.010. PMID: 29132528.

4. Ananthakrishnan A, Bernstein C, Iliopoulos D, et al. 2018; Environmental triggers in IBD: a review of progress and evidence. Nat Rev Gastroenterol Hepatol. 15:39–49. DOI: 10.1038/nrgastro.2017.136. PMID: 29018271.

5. Gudmand-Hoyer E, Jarnum S. 1970; Incidence and clinical significance of lactose malabsorption in ulcerative colitis and Crohn's disease. Gut. 11:338–343. DOI: 10.1136/gut.11.4.338. PMID: 5468136. PMCID: PMC1411415.

6. Kirschner BS, DeFavaro MV, Jensen W. 1981; Lactose malabsorption in children and adolescents with inflammatory bowel disease. Gastroenterology. 81:829–832. DOI: 10.1016/S0016-5085(81)80104-7. PMID: 6895202.

7. Deng Y, Misselwitz B, Dai N, Fox M. 2015; Lactose intolerance in adults: biological mechanism and dietary management. Nutrients. 7:8020–8035. DOI: 10.3390/nu7095380. PMID: 26393648. PMCID: PMC4586575.

8. Barrett JS, Irving PM, Shepherd SJ, Muir JG, Gibson PR. 2009; Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders. Aliment Pharmacol Ther. 30:165–174. DOI: 10.1111/j.1365-2036.2009.04018.x. PMID: 19392860.

9. Peyrin-Biroulet L, Reinisch W, Colombel JF, et al. 2014; Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut. 63:88–95. DOI: 10.1136/gutjnl-2013-304984. PMID: 23974954.

10. Mishkin , S . 1997; Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 65:564–567. DOI: 10.1093/ajcn/65.2.564. PMID: 9022546.

11. Mattar R, de Campos Mazo DF, Carrilho FJ. 2012; Lactose intolerance: diagnosis, genetic, and clinical factors. Clin Exp Gastroenterol. 5:113–121. DOI: 10.2147/CEG.S32368. PMID: 22826639. PMCID: PMC3401057.

12. Halmos EP, Christophersen CT, Bird AR, Shepherd SJ, Muir JG, Gibson PR. 2016; Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn's disease: a randomised, controlled cross-over trial of well-defined diets. Clin Transl Gastroenterol. 7:e164. DOI: 10.1038/ctg.2016.22. PMID: 27077959. PMCID: PMC4855163.

13. Eadala P, Matthews SB, Waud JP, Green JT, Campbell AK. 2011; Association of lactose sensitivity with inflammatory bowel disease--demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther. 34:735–746. DOI: 10.1111/j.1365-2036.2011.04799.x. PMID: 21815901.

14. Szilagyi A, Galiatsatos P, Xue X. 2016; Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 15:67. DOI: 10.1186/s12937-016-0183-8. PMID: 27411934. PMCID: PMC4942986.

15. Mishkin S. 1997; Dairy sensitivity, lactose malabsorption, and elimination diets in inflammatory bowel disease. Am J Clin Nutr. 65:564–567. DOI: 10.1093/ajcn/65.2.564. PMID: 9022546.

16. Mishkin B, Yalovsky M, Mishkin S. 1997; Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol. 92:1148–1153. PMID: 9219788.

17. Hüppe D, Tromm A, Langhorst H, May B. 1992; Lactose intolerance in chronic inflammatory bowel diseases. Dtsch Med Wochenschr. 117:1550–1555. DOI: 10.1055/s-2008-1062476. PMID: 1396146.

18. Wright R, Truelove SC. 1965; A controlled therapeutic trial of various diets in ulcerative colitis. Br Med J. 2:138–141. DOI: 10.1136/bmj.2.5454.138. PMID: 14304053. PMCID: PMC1845668.

19. Furnari M, Bonfanti D, Parodi A, et al. 2013; A comparison between lactose breath test and quick test on duodenal biopsies for diagnos-ing lactase deficiency in patients with self-reported lactose intolerance. J Clin Gastroenterol. 47:148–152. DOI: 10.1097/MCG.0b013e31824e9132. PMID: 22495813.

20. Misselwitz B, Pohl D, Frühauf H, Fried M, Vavricka SR, Fox M. 2013; Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United European Gastroenterol J. 1:151–159. DOI: 10.1177/2050640613484463. PMID: 24917953. PMCID: PMC4040760.